Patient reported outcome measures in clinical practice

Size: px
Start display at page:

Download "Patient reported outcome measures in clinical practice"

Transcription

1 Patient reported outcome measures in clinical practice Brought to you by Pfizer Limited Date of preparation: August 2016; Job code: PP-GEP-GBR

2 Objective To provide healthcare professionals (HCPs) with an introduction to patient reported outcomes measures (PROMs), and how they are important in developing a patientcentred approach to care 2

3 Learning outcomes Upon completion of this module, the participant will be able to: 1. Demonstrate an increase in, or affirmation of, their knowledge of patient reported outcome (PRO) research in terms of: Understanding the meaning and purpose of PRO research Recognising the different types of measures used in PRO research 2. Identify and utilise PROMs for the needs of the patient and for their clinical setting 3. Understand how to synthesise findings from PRO research studies 3

4 Content overview The principles of PRO research Self-assessment quiz PROs The applications of PROMs in clinical practice Conclusions PRO clinical case study 4

5 The principles of PRO research 5

6 What is PRO research? PRO research can be defined as: Any report on the status of a patient s health condition that comes directly from the patient, without interpretation of the response by a clinician or anybody else 1,2 PRO research takes into consideration, and stresses the importance of, research that is informed by the perspectives, interests and values of the patient, 2 and are used to evaluate the effect of treatment on how a patient feels or functions 3 PROs are used when measuring a concept that is best known by the patient or measured from the perspective of the patient 4 Other than reporting of outcomes by the patients themselves, a proxy-reported outcome is a measurement based on a report by someone other than the patient, reporting as if he or she is the patient 5 An observer (e.g. caregiver) may give a measure based on their opinion, referred to as an observerreported outcome 5 PROMs are typically based on questionnaires, referred to as PRO instruments, that are based on health and quality of life 6 PROs are often used to evaluate change in health status over time with PRO instruments administered at baseline and during/or after treatment, or when a certain milestone has been reached 7 1. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research. Health Qual Life Outcomes 2006;4:79; 2. Snyder CF, et al. Med Care 2013;51:S73 9; 3. Rothman M, et al. Value Health 2009;12: ; 4. Coons SJ, et al. Value Health 2009;12:419 29; 5. Matza LS, et al. Value Health 2013;16:461 79; 6. Spiegal BM. 6 J Neurogastroenterol Motil 2013;19:137 48; 7. Nixon A, et al. Health Qual Life Outcomes 2016;14:25.

7 What instruments are used to assess PROs? PRO instruments collect data across several areas of health, including physical, psychological and social functioning, and are generally classed as either generic or disease-specific 1 Generic PRO instruments 2 Disease-specific PRO instruments 2 Overall state of the condition e.g. angina Overall feelings about a condition or treatment e.g. worry about the condition deteriorating General disease concepts e.g. physical functioning Specific disease concepts e.g. frequency/severity of symptoms Treatment side effects e.g. severity of adverse events 1. Spiegal BM. J Neurogastroenterol Motil 2013;19:137 48; 2. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research. Health Qual Life Outcomes 2006;4:79. 7

8 Advantages and disadvantages of PRO instruments Generic PRO instruments 1 Advantages Suitable for the general public and for comparisons across populations Suitable for comparisons with disparate conditions/disease groups Captures commonly experienced health domains Disadvantages Content may be redundant for certain conditions/illnesses Not sensitive to detecting disease-specific illnesses Disease-specific PRO instruments 1 Advantages Specific for a given group (disease/population) Sensitive enough to detect clinically significant changes Captures clinically-relevant information that is applicable to a specific target group Disadvantages Cannot compare with the general population 1. Snyder CF, et al. Qual Life Res 2012;21:

9 Examples of PRO instruments Physical function Role physical Bodily pain General health Generic PRO instruments measure health across several areas, examples described below are the short-form health questionnaire (SF-36) and the EuroQOL five dimensions questionnaire (EQ-5D) 1,2 A large number of disease-specific PRO instruments have been developed, for example over 110 PRO instruments have been developed in gastroenterology alone 1 SF-36 Includes 36 items that are organised into eight discrete domains 1,3 Physical Mental Mental health Role emotional Social function Vitality EQ-5D Measures health-related quality of life (HRQoL) in five distinct domains 2 Anxiety /depression Pain/discomfort Mobility EQ-5D domains Self-care Usual activities 1. Spiegal BM. J Neurogastroenterol Motil 2013;19:137 48; 2. Brettschneider C, et al. Health and Quality of Life Outcomes 2013;11:3; 3. Chiu Y-W, et al. Clin J Am 9 Soc Nephrol 2009;4:

10 Administering PRO instruments Responses to PRO instruments can be gathered through a number of different channels 1,2,3 Telephone Paper Personal Low technology and Convenient cost Only requires Not for the illiterate auditory Can lose data proficiency Resource Computer/Internet intensive Impersonal if using automated systems Efficient Interview Resource intensive May encourage patients to report sensitive information Personal Can be linked to electronic health records Doesn t require Immediate scoring and presentation is literacy possible Can be more in-depth May allow for real-time data interpretation and allows for inperson explanation and timely interventions Mail Larger recruitment catchment area, less Expensive restricted by geographies and boundaries Invasive Low tech and cost Smaller investment in staff time and cost Can lose data savings Resource intensive Requires trained personnel and software High technical costs and initially expensive 1. Liu H, et al. J Clin Epidemiol 2010;63: ; 2. Snyder CF, et al. Qual Life Res 2012;21: ; 3. Coons SJ, et al. May require training of patients Value Health 2009;12: Data privacy is an issue 10

11 Why do we need PRO studies? Patient-centred care is an emerging concept in healthcare and can be defined as: Understanding of the patient s thoughts, feelings, and expectations in the context of their illnesses in order to reach a common ground for integrated management 1 PROMs can be used to gauge patient opinion on their care and improve clinical practice 2 PROMs can be used to quantify consequences of interventions and quality of life following an intervention 3 Multiple stakeholders including, patients, payors, government bodies and the general public are interested in measuring the effects of a medical intervention 4 PROs are also important from an pharmacoeconomic perspective and are used when calculating quality-adjusted life years 5 Impro ve care Gather data from PRO instru ments Feedb ack results Analys is of PRO data 1. Lam CLK, et al. Front Med (Lausanne) 2014;1:29; 2. Kotronoulas G, et al. J Clin Oncol 2014;32: ; 3. Weldring T and Smith SM. Health Services Insights 2013;6:61 8; 4. Banerjee AK, et al. Drug Safety 2013;36: ; 5. Appleby J, et al. J R Soc Med 2013;106:

12 The applications of PROMs in clinical practice 12

13 How are PROMs used in clinical practice? PRO research generates measures, referred to as PROMS, that can be used to inform clinical practice 1 A one-time assessment may help to identify problems that would otherwise have gone unnoticed 1 Multiple assessments can track patient outcomes over time and may help to modify treatments, as required 1 As a screening and treatment monitoring tool Linking to disease registries Part of a patient-centred approach to care As a treatment decision aid Linking PROMs to disease registries offers a cost-effective way to gather real-world data on disease progression and treatment outcomes 2 Helps to facilitate discussions between patients and clinicians regarding patient issues, including concerns and priorities for care 1 Helps patients understand the treatment options that are available and assists in the selection of a treatment that is most suitable to the individual patient 1 1. International Society for Quality of Life Research. User s Guide to Implementing Patient-Reported Outcomes Assessment in Clinical Practice. Can be accessed from: 2. Ashley L, et al. J Med Internet Res 2013;15:e

14 Using PROMs as a treatment monitoring tool Linking PROMs to treatment outcomes provides an opportunity to monitor quality of life while undergoing treatment 1 Example: Monitoring treatment and HRQoL using PRO instruments in patients with metastatic breast, genitourinary, gynaecologic, or lung cancer Objectives Patients Assessments Use PRO instruments to monitor symptoms and HRQoL during cancer treatment Patients were randomised to report symptoms via an electronic device or means at the discretion of clinicians HRQoL was evaluated using the EQ-5D PRO instrument at 6 months Outcomes Patients who reported symptoms via an electronic device improved HRQoL compared with means at the clinicians discretion 1. Basch E, et al. J Clin Oncol 2015; Dec 7. pii: JCO [Epub ahead of print]. 14

15 Linking PROMs to disease registries Linking PROMs to disease registries allows the practitioner to gather real-world data in real time 1 Example The electronic Patient-reported Outcomes from Cancer Survivors (epocs) system Objectives Link PROMs to disease registries for recently diagnosed patients with breast, colorectal, and prostate cancer Assessments Six different PRO instruments were administered at 6, 9 and 15 months, post diagnosis Participation Patient participation was 55.21% (636/1152) overall, although this varied by mode of approach Participation was considerably higher among patients approached face-to-face (61.4%, 490/798) compared with telephone (48.8%, 21/43) or by letter (41.0%, 125/305) Outcomes The PROMs were successfully linked with cancer registry data for 100% of patients (N=636) 1. Ashley L, et al. J Med Internet Res 2013;15:e

16 Implementing PROMs into clinical practice Implementing PROMs into clinical practice typically involves the consideration of a number of factors 1 1. Identifying the goals for collecting PROMs 2. Selecting patients, settings and timings of assessments 3. Determining which PRO instrument to use 4. Mode for administration and scoring PROMs 5. Reporting results 6. Interpreting scores 7. Responding to issues identified by the PROMs 8. Evaluating the impact that PROMs may have on clinical practice 1. Snyder CF, et al. Qual Life Res 2012;21:

17 Challenges associated with PRO research There are some difficulties associated with developing PRO research 1,2 Poor literacy and understanding of PRO instruments 1 Challenge: Patients with low literacy may fail to understand some questions Solution: Format the PRO instrument so that it is easy to follow and use illustrations where appropriate Additional costs 2 Challenge: Additional costs required to implement PRO research, such as training, administration and data interpretation Validation: It would be expected that the additional costs are offset by the benefits to the patient and the practitioner 1. Jahagirdar D, et al. BMC Health Serv Res 2012;12:431; 2. Antunes B, et al. Palliative Med 2014;28:

18 PRO clinical case study: Northumbria NHS Healthcare Foundation Trust: The use of PROMs to assess the impact of knee replacement surgery 18

19 Case study background The programme An NHS programme that began in April 2009 in the United Kingdom (UK) that used PRO instruments to evaluate health before and after elective knee replacement, hip replacement, varicose vein and groin hernia surgeries 1 1. Basser MR. Health and Social Care Information Centre. Can be accessed from: PROMs-benefits-case-study/pdf/promscasestudy.pdf. Copyright 2016, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved 19

20 Implementing PROMs in clinical research The objectives of the study To use PROMs to inform service changes and enable providers and other stakeholders to improve quality of care To empower patients and clinicians to make an informed choice on the course of treatment Selecting patients The programme selected patients that were to undergo elective knee replacement, hip replacement, varicose vein and groin hernia surgery Timing of assessment STEP 1 Identifying goals STEP 2 Identifying patients Pre-operative and post-operative PRO instruments were used to assess whether patient health improved following surgery; post-operative questionnaires STEP 2 were sent out 3 and 6 months after treatment Timing assessments 1. Basser MR. Health and Social Care Information Centre. Can be accessed from: PROMs-benefits-case-study/pdf/promscasestudy.pdf. Copyright 2016, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved 20

21 Selecting the PRO instrument The generic PRO instruments that were used for all procedures were: EQ-5D Index Patients provided responses to five questions, each covering a distinct health domain 1. Mobility 2. Self-care 3. Performing usual activities 4. Pain/discomfort 5. Anxiety/depression Patients rated their health on one of three levels, ranging from no problems to severe problems EQ Visual Analogue Scale (EQ VAS) Patients rated their general health on an analogue linear scale ranging between 0 and 100, with 100 representing the best state of health 1. Basser MR. Health and Social Care Information Centre. Can be accessed from: PROMs-benefits-case-study/pdf/promscasestudy.pdf. Copyright 2016, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved STEP 3 & 4 Selecting PRO instruments 21

22 Disease-specific PRO instruments The disease-specific PRO instruments selected were: STEP 3 & 4 Oxford Hip Score Oxford Knee Score Aberdeen Varicose Questionnaire Selecting PRO instruments 12 questions relating to the patient s hip (Oxford Hip Score) or knee (Oxford knee score) and how it s condition affects quality of life Responses combined to give an overall score, ranging from 0 (worst possible score) to 48 (best possible score) 13 questions relating to the patient s varicose veins The responses are combined into an index, ranging from 0 (best possible score) to 100 (worst possible score) 1. Basser MR. Health and Social Care Information Centre. Can be accessed from: PROMs-benefits-case-study/pdf/promscasestudy.pdf. Copyright 2016, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved 22

23 Linking PROMS to clinical outcomes Identifying an unmet need PROMs demonstrated that the Northumbria NHS Healthcare Foundation Trust was below the UK average for adjusted health gain following replacement knee surgery STEP 5 & 6 Reporting results Interpreting PROMs Analysis of PROMs PROMs were linked to the National Joint Registry data for 22,691 primary total knee replacements to detect a correlation between PROMs scores and various surgical factors, including STEP 7 surgical implants Responding Linking PROMs to clinical outcomes to issues One implant brand (brand C) returned the highest health gain for the Oxford Knee Score, compared with two other brands (brands A and B). 1. Basser MR. Health and Social Care Information Centre. Can be accessed from: PROMs-benefits-case-study/pdf/promscasestudy.pdf. Copyright 2016, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved 23

24 Evaluating clinical practice informed by PROMs The Northumbria NHS Foundation Trust moved to solely using the knee replacement implant brand C that demonstrated the superior Oxford Knee Score To assess the effectiveness of the implant brand change, Northumbria Healthcare Foundation Trust analysed 1623 completed PRO instruments for the period April 2009 to March 2014 STEP 8 Evaluating the impact on clinical practice Brand Number of primary knee replacement surgeries Adjusted health gain for Oxford Knee Score Implant brand A Implant brand B Implant brand C Total 1623 N/A The analysis showed that changing to implant brand C significantly improved adjusted health gain scores for the Oxford Knee Score 1. Basser MR. Health and Social Care Information Centre. Can be accessed from: PROMs-benefits-case-study/pdf/promscasestudy.pdf. Copyright 2016, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved 24

25 Conclusions 25

26 Summary PRO instruments help to encourage a patient-centric approach to care 1 PRO instruments are typically questionnaires that collect data across several areas of health, including physical, psychological and social functioning 2 o PRO instruments can be either generic or disease-specific PROMs can be used to influence clinical practice in a number of ways, these include: o As a screening tool to identify conditions/symptoms that would otherwise have been overlooked 3 o To monitor treatment and respond to patient outcomes over time 3 o To aid treatment choices and assist in selecting treatments that are most suited to the patient 3 Limitations of PROMs include comprehension of PRO instruments and associated costs of implementing and evaluating results 4,5 o However, PRO instruments can be improved for comprehension and the clinical benefits of implementing changes as a result of PROMs can offset initial economic costs 4,5 1. Lam CLK, et al. Front Med (Lausanne) 2014;1:29; 2. Spiegal BM. J Neurogastroenterol Motil 2013;19:137 48; 3. International Society for Quality of Life Research. Us Guide to Implementing Patient-Reported Outcomes Assessment in Clinical Practice. Can be accessed from: 4. Jahagirda 26 al.

27 Further reading 1. Health and Social Care Information Centre. Can be accessed from: Patient-reported outcomes: Measurements, implementation and interpretation (Chapman & Hall/CRC Biostatistics Series). Cappelleri JC, Zou KH, Bushmakin AG, Alvir JJ, Alemayehu D, Symonds T. CRC Press Taylor & Francis Group. 3. Nelson EC, et al. Patient-reported outcome measures in practice. BMJ 2015; Feb 10;350:g7818. doi: /bmj.g Santan Mj, et al. Training clinicians in how to use patient-reported outcome measures in routine clinical practice. Qual Life Res 2015;24:

28 Self-assessment quiz 28

29 Question 1 How many health domains does the SF-36 PRO instrument evaluate? 1. Eight 2. Six 3. Four 4. Two 29

30 Question 2 How many health domains does the EQ-5D PRO instrument evaluate? 1. Two 2. Four 3. Five 4. Eight 30

31 Question 3 Which of the following is not a type of PRO instrument? 1. Disease-specific 2. Individual patient-specific 3. Generic 31

32 Question 4 Which of the following is a disadvantage of disease-specific PRO instruments? 1. Specific for a given group (disease/population) 2. Sensitive enough to detect clinically significant changes 3. Captures clinically-relevant information that is applicable to a specific target group 4. Cannot compare with the general population 32

33 Question 5 Which of the following is a disadvantage of generic PRO instruments? 1. Suitable for the general public and for comparisons across populations 2. Suitable for comparisons with disparate conditions/disease groups 3. Captures commonly experienced health domains 4. Not sensitive to detecting disease-specific illnesses 33

34 Question 6 Which of the following is a potential drawback to PRO research 1. PROs are a poor reflection of the patient experience 2. Exclusion of patients due to poor literacy 3. An inability to link PRO outcomes to clinical registries 34

35 Question 7 Linking PROMs with clinical registries allows the clinician to establish: 1. Real world, retrospective data as it is processed 2. Prospective, randomised data 35

36 Question 8 Which of the following uses for PROMs is not true? PROMs can be used in clinical practice: 1. As a screening and monitoring tool 2. To replace randomised clinical trials to monitor the efficacy and safety of a treatment 3. As part of a patient-centred approach to care 4. As a treatment decision aid 36

37 Question 9 The SF-36 and EQ-5D PRO instruments are examples of a: 1. Generic PRO instrument 2. Disease-specific PRO instrument 37

38 Question 10 To compare the quality of life of a patient with a specific disease with that of healthy individuals, which of the two types of PRO instrument should be used? 1. Generic 2. Disease-specific 38

Patient Reported Outcomes: are they appropriate for clinical practice? Jose M Valderas Clinical Lecturer

Patient Reported Outcomes: are they appropriate for clinical practice? Jose M Valderas Clinical Lecturer Patient Reported Outcomes: are they appropriate for clinical practice? Jose M Valderas Clinical Lecturer Key issues What are PROMs? Why PROMs? Assessing PROMs Interpreting PROMs Evidence for use in clinical

More information

The PROMs Programme in the NHS in England

The PROMs Programme in the NHS in England The PROMs Programme in the NHS in England Veena Raleigh Senior Fellow, The King s Fund HCQI, 7 November 2013 The background Improving NHS quality a government priority since 2008 Quality defined as: effectiveness,

More information

Analysis of Patient Reported Outcomes Measures

Analysis of Patient Reported Outcomes Measures Analysis of Patient Reported Outcomes Measures Pre-Operative Health Status Data April 2009 to March 2010 Commissioning Analysis and Intelligence & System Management and New Enterprise DH Information Reader

More information

Finalised Patient Reported Outcome Measures (PROMs) in England

Finalised Patient Reported Outcome Measures (PROMs) in England Finalised Patient Reported Outcome Measures (PROMs) in England April 2015 to March Published 10 August 2017 PROMs measures health gain in patients undergoing hip and knee replacement, varicose vein treatment

More information

Objectives. Context. Wider NHS context 5/24/2017. Technology in palliative care. Technology enabled Care (TEC)

Objectives. Context. Wider NHS context 5/24/2017. Technology in palliative care. Technology enabled Care (TEC) Objectives Historical context of IT systems in the NHS over the last 10 years Technology in palliative care Background to telemedicine pros and cons / criticisms The changing digital landscape of healthcare

More information

Life After Prostate Cancer Diagnosis Research Study

Life After Prostate Cancer Diagnosis Research Study Life After Prostate Cancer Diagnosis Research Study If you are looking at this information sheet this means you have read the covering letter and therefore have had a diagnosis of prostate cancer. If you

More information

PRO ASSESSMENT IN CANCER TRIALS. Emiliano Calvo, Anita Margulies, Eric Raymond, Ian Tannock, Nadia Harbeck and Lonneke van de Poll-Franse

PRO ASSESSMENT IN CANCER TRIALS. Emiliano Calvo, Anita Margulies, Eric Raymond, Ian Tannock, Nadia Harbeck and Lonneke van de Poll-Franse PRO ASSESSMENT IN CANCER TRIALS Emiliano Calvo, Anita Margulies, Eric Raymond, Ian Tannock, Nadia Harbeck and Lonneke van de Poll-Franse DISCLOSURES Emiliano Calvo has reported no conflicts of interest

More information

Outcomes that Matter to Patients

Outcomes that Matter to Patients Outcomes that Matter to Patients Patient Reported Outcome Measures (PROMs) : Progress and What Next? Rafael Goriwoda Senior Analytical Manager NHS England The national PROMs programme so far The first

More information

Quality of Life Metric

Quality of Life Metric Quality of Life Metric 20 March 2018 Chris Harrison National Clinical Director for Cancer, NHSE Messages 1. More people surviving cancer this is a success story! But, there is more to life than survival.

More information

QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For. Research Staff

QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For. Research Staff QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For Research Staff Contents What is Quality of Life?.. 1 QOL in Cancer Trials. 2 How is QOL Measured?....3 EORTC Questionnaires.....4 FACIT Questionnaires..

More information

INGUINAL HERNIA SURGERY: IMPROVING PATIENT OUTCOMES AND REDUCING VARIATION

INGUINAL HERNIA SURGERY: IMPROVING PATIENT OUTCOMES AND REDUCING VARIATION HERNIA INGUINAL HERNIA SURGERY: IMPROVING PATIENT AND REDUCING VARIATION Page 2 HERNIA INGUINAL HERNIA SURGERY: IMPROVING PATIENT AND REDUCING VARIATION CONTENTS 4 Executive summary 6 Restricting inguinal

More information

National Cancer Survivorship Initiative

National Cancer Survivorship Initiative National Cancer Survivorship Initiative National Cancer PROMS Programme DH PROMs & Cancer Policy Teams Originally. NHS England Now. ADAM GLASER Background Increasing prevalence of cancer increase of 3.2%

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after

More information

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin Qualitative Methods and Patient Reported Outcome Measures Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin Disclosures None Overview What is it? When is it useful? Why do it?

More information

Developing and validating the MSK-HQ Musculoskeletal Health Questionnaire

Developing and validating the MSK-HQ Musculoskeletal Health Questionnaire Developing and validating the MSK-HQ Musculoskeletal Health Questionnaire Dr Jonathan Hill Senior Lecturer in Physiotherapy Funded by Arthritis Research UK and NHS England The MSK is rapidly being rolled

More information

Leeds Institute of Health Sciences School of Medicine

Leeds Institute of Health Sciences School of Medicine Design and development of an electronic system for pain reporting in palliative care Dr Matthew Allsop, Dr Sally Taylor, Prof Rick Jones, Prof Mike Bennett, Dr Bridgette Bewick Academic Unit of Palliative

More information

2010 National Survey. East Kent Hospitals University NHS Trust

2010 National Survey. East Kent Hospitals University NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. The North West London Hospitals NHS Trust

2010 National Survey. The North West London Hospitals NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. The Leeds Teaching Hospitals NHS Trust

2010 National Survey. The Leeds Teaching Hospitals NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. University College London Hospitals NHS Foundation Trust

2010 National Survey. University College London Hospitals NHS Foundation Trust National Cancer Patient Experience Programme 2010 National Survey University College London Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme

More information

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust National Cancer Patient Experience Programme 2010 National Survey Northern Lincolnshire and Goole Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme

More information

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA Quality ID #109: Osteoarthritis (OA): Function and Pain Assessment National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples - Madeleine King & Richard De Abreu Lourenco- Overview Learning Objectives To discuss

More information

Health Services Research and Health Economics. Paul McCrone Institute of Psychiatry, King s College London

Health Services Research and Health Economics. Paul McCrone Institute of Psychiatry, King s College London Health Services Research and Health Economics Paul McCrone Institute of Psychiatry, King s College London Key Questions What is the rationale for considering health economics? What are the key components

More information

Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements

Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics John D Peipert Ron D Hays Acknowledgements Funding for this work provided by the Kidney Care Quality Alliance 1 Patient

More information

Japan Journal of Medicine

Japan Journal of Medicine 29 Japan Journal of Medicine 28; (6): 29-296. doi:.3488/jjm.3 Research article An International comparative Study on EuroQol-5-Dimension Questionnaire (EQ-5D) tariff scores between the and Japan Tsuguo

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. East Kent Hospitals University NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. East Kent Hospitals University NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit

NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit NBOCA: Feasibility Study Date of publication: Thursday 9 th August

More information

GREATER MANCHESTER EXPERIENCE

GREATER MANCHESTER EXPERIENCE Greater Manchester Cancer Vanguard Innovation Remote Monitoring / Stratified Pathways GREATER MANCHESTER EXPERIENCE NADEEM AHMED - INFORMATICS ENTERPRISE ARCHITECT, DIGITAL PROJECTS @ The Christie Previously

More information

Migrating a PRO Instrument. Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket)

Migrating a PRO Instrument. Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket) Migrating a PRO Instrument Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket) Presenter Biographies Serge Bodart is currently based in Montreal, Canada. He has been involved

More information

Patient reported outcome measures (PROMs) in HIV

Patient reported outcome measures (PROMs) in HIV WHO Collaborating Centre Patient reported outcome measures (PROMs) in HIV Dr Katherine Bristowe Cicely Saunders Institute King s College London Competing or Conflicting Interests None. Background: problems

More information

Patient Reported Outcomes in Sickle Cell Disease. Marsha J. Treadwell, PhD 5 October 2016

Patient Reported Outcomes in Sickle Cell Disease. Marsha J. Treadwell, PhD 5 October 2016 Patient Reported Outcomes in Sickle Cell Disease Marsha J. Treadwell, PhD 5 October 2016 Outline Provide brief overview of key health domains affected by sickle cell disease and that can be measured by

More information

National Cancer Patient Experience Survey Results. Milton Keynes University Hospital NHS Foundation Trust. Published July 2016

National Cancer Patient Experience Survey Results. Milton Keynes University Hospital NHS Foundation Trust. Published July 2016 National Cancer Patient Experience Survey 2015 Results Milton Keynes University Hospital NHS Foundation Trust Published July 2016 The National Cancer Patient Experience Survey is undertaken by Quality

More information

The EuroQol and Medical Outcome Survey 36-item shortform

The EuroQol and Medical Outcome Survey 36-item shortform How Do Scores on the EuroQol Relate to Scores on the SF-36 After Stroke? Paul J. Dorman, MD, MRCP; Martin Dennis, MD, FRCP; Peter Sandercock, MD, FRCP; on behalf of the United Kingdom Collaborators in

More information

(Making) Shared Decision Making Part of Usual Care

(Making) Shared Decision Making Part of Usual Care N N E A C C N O R T H E R N N E W E N G L A N D A C C O U N T A B L E C A R E C O L L A B O R A T I V E (Making) Shared Decision Making Part of Usual Care Healthy Dialogues August 26, 2014 David E Wennberg,

More information

NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica

NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica Steven Vogel Vice Principal (Research), The British School of Osteopathy Editor-in-Chief, The

More information

National Cancer Patient Experience Programme National Survey. Royal National Orthopaedic Hospital NHS Trust. Published September 2014

National Cancer Patient Experience Programme National Survey. Royal National Orthopaedic Hospital NHS Trust. Published September 2014 National Cancer Patient Experience Programme 2014 National Survey Royal National Orthopaedic Hospital NHS Trust Published September 2014 The National Cancer Patient Experience Survey Programme is undertaken

More information

Initiatives in Australia

Initiatives in Australia Initiatives in Australia closing disparities in cancer for Indigenous Australians Professor Gail Garvey gail.garvey@menzies.edu.au Apology Ten Year Anniversary 'Sorry' apology to Stolen Generations.

More information

XX Encuentro de Economía Pública Sevilla, 31 de enero y 1 de febrero de 2013

XX Encuentro de Economía Pública Sevilla, 31 de enero y 1 de febrero de 2013 XX Encuentro de Economía Pública Sevilla, 31 de enero y 1 de febrero de 2013 Comparing hospital quality performance estimates based on different patientreported outcome measures Ana Luisa Godoy Caballero

More information

Using EQ-5D to measure patient reported outcomes

Using EQ-5D to measure patient reported outcomes Using EQ-5D to measure patient reported outcomes April 2017 Liz Vernon-Wilson Outcomes Researcher Tom Rudd Unit, Moorgreen Hospital 1 Introducing PROM data EQ-5D-5L is a Patient Reported Outcome Measure

More information

Patient Reported Outcomes

Patient Reported Outcomes Date Patient Reported Outcomes Presented by: Ari Gnanasakthy RTI Health Solutions 9 th Feb 2015 RTI Health Solutions Research Triangle Park, NC, USA Ann Arbor, MI, USA Barcelona, Spain Ljungskile, Sweden

More information

National Cancer Patient Experience Survey Results. University Hospitals of Leicester NHS Trust. Published July 2016

National Cancer Patient Experience Survey Results. University Hospitals of Leicester NHS Trust. Published July 2016 National Cancer Patient Experience Survey 2015 Results University Hospitals of Leicester NHS Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is undertaken

More information

National Cancer Patient Experience Survey Results. East Kent Hospitals University NHS Foundation Trust. Published July 2016

National Cancer Patient Experience Survey Results. East Kent Hospitals University NHS Foundation Trust. Published July 2016 National Cancer Patient Experience Survey 2015 Results East Kent Hospitals University NHS Foundation Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is

More information

Cancer in First Nations People in Ontario:

Cancer in First Nations People in Ontario: Cancer in First Nations People in Ontario: Incidence, Mortality, Survival and Prevalence 1 of 12 Prostate Cancer in First Nations People in Ontario Outline This chapter will discuss the following: What

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #109: Osteoarthritis (OA): Function and Pain Assessment National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

PATIENT REPORTED OUTCOMES

PATIENT REPORTED OUTCOMES Introduction to Clinical Research: A Two-week Intensive Course PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Overview 1. Importance of patient perspective 2. Definitions 3. Key concepts to measure as

More information

In 2017, we are proud to have supported the following patient organisations:

In 2017, we are proud to have supported the following patient organisations: SERVIER LABORATORIES LTD YEAR ENDED 31 ST DECEMBER 2017 PATIENT ORGANISATIONS In 2017, we are proud to have supported the following patient organisations: Lymphoma Association The Lymphoma Association

More information

Basic Economic Analysis. David Epstein, Centre for Health Economics, York

Basic Economic Analysis. David Epstein, Centre for Health Economics, York Basic Economic Analysis David Epstein, Centre for Health Economics, York Contents Introduction Resource use and costs Health Benefits Economic analysis Conclusions Introduction What is economics? Choices

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. James Paget University Hospitals NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. James Paget University Hospitals NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

FAQ ON QUANTUM HEALTH ANALYZER

FAQ ON QUANTUM HEALTH ANALYZER FAQ ON QUANTUM HEALTH ANALYZER What is Quantum Health Analyzer? The Quantum Health Analyzer measures the degree and type of response of a matter under test, and by comparison with reference matter it assists

More information

Critical Reviews in Oncology/Hematology 33 (2000)

Critical Reviews in Oncology/Hematology 33 (2000) Critical Reviews in Oncology/Hematology 33 (2000) 99 103 www.elsevier.com/locate/critrevonc Assessing the relative costs of standard open surgery and laparoscopic surgery in colorectal cancer in a randomised

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. Milton Keynes Hospital NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. Milton Keynes Hospital NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview.

Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview. Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview. Document Title An Overview of Commissioning Living with and Beyond Cancer in Yorkshire and Humber Version number: 1 First

More information

Integrated IAPT Data Guide

Integrated IAPT Data Guide Version Date Summary of changes Draft Nov 16 Initial version for feedback at early implementer workshop v3 Feb 17 Iterated version on Yammer for feedback v4 March 17 Version agreed at Outcomes & Informatics

More information

National Cancer Patient Experience Programme National Survey. South Tees Hospitals NHS Foundation Trust. Published September 2014

National Cancer Patient Experience Programme National Survey. South Tees Hospitals NHS Foundation Trust. Published September 2014 National Cancer Patient Experience Programme 2014 National Survey South Tees Hospitals NHS Foundation Trust Published September 2014 The National Cancer Patient Experience Survey Programme is undertaken

More information

The Welsh Liberal Democrats plan to provide an effective cancer strategy for Wales

The Welsh Liberal Democrats plan to provide an effective cancer strategy for Wales Wales Can Tackle Cancer: The Welsh Liberal Democrats plan to provide an effective cancer strategy for Wales Index Page One : Foreword Page Two: No Comprehensive Caner Plan in Wales Page Three: IMRT - Wales

More information

Practical use of APCA African POS: research and audit

Practical use of APCA African POS: research and audit Practical use of APCA African POS: research and audit Dr Liz Gwyther MB ChB FCFP MSc Pall Med Palliative Medicine Programme Faculty of Health Sciences University of Cape Town Development and validation

More information

Specialist HIV Outpatient Physiotherapy Service

Specialist HIV Outpatient Physiotherapy Service Specialist HIV Outpatient Physiotherapy Service Darren Brown Physiotherapist Chelsea and Westminster Hospital NHS Foundation Trust London, United Kingdom @darrenabrown @ChelWestFT - 3rd International Forum

More information

David Patterson The Whittington Hospital, Magdala Avenue, London N19 5NF, UK

David Patterson The Whittington Hospital, Magdala Avenue, London N19 5NF, UK Refereed article Comparison of howru and EQ-5D measures of health-related quality of life in an outpatient clinic Tim Benson Routine Health Outcomes Ltd., 14 Pinewood Crescent, Hermitage, Thatcham RG18

More information

P powered by. Patient Experience

P powered by. Patient Experience P powered by Patient Experience P : game changer in improving cancer patient outcomes Digital Personalised Medicine Solutions...the use of anonymised, real-time improving patient experience & Patient Reported

More information

Health Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017

Health Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017 Health Related Quality of Life: Cancer cachexia Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017 Overview to lecture Introduction/Scotland Patient related outcome measures

More information

Incorporating the patient voice in sarcoma research:

Incorporating the patient voice in sarcoma research: Incorporating the patient voice in sarcoma research: How can we assess health-related quality of life in this heterogeneous patient groep? Olga Husson PhD Institute of Cancer Research, Division of Clinical

More information

Patient Reported Outcome Measures in England

Patient Reported Outcome Measures in England Patient Reported Outcome Measures in England Data Dictionary Version 3.4. Author: Secondary Care Analysis (PROMs), NHS Digital Responsible Statistician: Jane Winter NHS Digital is the trading name of the

More information

Electronic Capture of PROs in NCI Clinical Trials

Electronic Capture of PROs in NCI Clinical Trials Electronic Capture of PROs in NCI Clinical Trials Lori Minasian, MD, FACP Deputy Director, Division of Cancer Prevention, NCI July 27, 2017 Vision for PROs in NCI Clinical Trials Incorporate patient reported

More information

MOVEMBER FUNDED MEN S HEALTH INFORMATION RESOURCES EVALUATION BRIEF. 1 P age

MOVEMBER FUNDED MEN S HEALTH INFORMATION RESOURCES EVALUATION BRIEF. 1 P age MOVEMBER FUNDED MEN S HEALTH INFORMATION RESOURCES EVALUATION BRIEF 1 P age Contents 1. Purpose... 3 2. Background... 3 3. beyondblue, the national depression and anxiety initiative... 4 4. Movember funded

More information

Measuring outcomes to improve the management of continence care. Dr Adrienne Rivlin KPMG Global Strategy Group

Measuring outcomes to improve the management of continence care. Dr Adrienne Rivlin KPMG Global Strategy Group Measuring outcomes to improve the management of continence care Dr Adrienne Rivlin KPMG Global Strategy Group Background of the study Many treatment options, few find a cure High quality daily continence

More information

Cost-Utility Analysis (CUA) Explained

Cost-Utility Analysis (CUA) Explained Pharmaceutical Management Agency Cost-Utility Analysis (CUA) Explained Cost-Utility Analysis (CUA) at PHARMAC Questions and Answers go to page 9 >> This document explains the process that PHARMAC generally

More information

GETTING IT RIGHT FIRST TIME National Professional Pilot

GETTING IT RIGHT FIRST TIME National Professional Pilot Professional Pilot South Tees Hospitals NHS Foundation Trust Constituent Hospitals: Friarage Hospital and The James Cook University Hospital Final Draft Provider Profile Report and Dashboard June 2014

More information

Agreement between Proxy and Patient Reports of HRQoL using the EQ-5D:

Agreement between Proxy and Patient Reports of HRQoL using the EQ-5D: Agreement between Proxy and Patient Reports of HRQoL using the EQ-5D: The interaction effect of perspective, timing and patient cognition Steven McPhail,2 Elaine Beller,2 Terry Haines,2 The University

More information

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data Volume 12 Number 1 2009 VALUE IN HEALTH Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data Lynda McKenzie, MSc, Marjon van der Pol, PhD

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/28958 holds various files of this Leiden University dissertation Author: Keurentjes, Johan Christiaan Title: Predictors of clinical outcome in total hip

More information

NICE DSU TECHNICAL SUPPORT DOCUMENT 8: AN INTRODUCTION TO THE MEASUREMENT AND VALUATION OF HEALTH FOR NICE SUBMISSIONS

NICE DSU TECHNICAL SUPPORT DOCUMENT 8: AN INTRODUCTION TO THE MEASUREMENT AND VALUATION OF HEALTH FOR NICE SUBMISSIONS NICE DSU TECHNICAL SUPPORT DOCUMENT 8: AN INTRODUCTION TO THE MEASUREMENT AND VALUATION OF HEALTH FOR NICE SUBMISSIONS REPORT BY THE DECISION SUPPORT UNIT August 2011 John Brazier 1 and Louise Longworth

More information

Has Consumer Directed Care improved the quality of life of older Australians? Professor Julie Ratcliffe School of Medicine Flinders University

Has Consumer Directed Care improved the quality of life of older Australians? Professor Julie Ratcliffe School of Medicine Flinders University Has Consumer Directed Care improved the quality of life of older Australians? Professor Julie Ratcliffe School of Medicine Flinders University Acknowledgments: ARC Linkage Project A Health Economics Model

More information

Published December 2015

Published December 2015 Published December 2015 Contents Executive summary 3 1. Introduction The changing story of cancer 6 2. Current state Poor performance 7 Fragmentation and duplication 7 Existing and developing programme

More information

Wyoming Quit Tobacco Program Follow-Up Survey

Wyoming Quit Tobacco Program Follow-Up Survey December 18, 2017 Wyoming Quit Tobacco Program Follow-Up Survey January June 2017 Interviews Muneyuki Kato, MA, Associate Research Scientist Tiffany Comer Cook, MS, Senior Research Scientist Laran H. Despain,

More information

Prof Marion Eckert Rosemary Bryant AO Research Centre

Prof Marion Eckert Rosemary Bryant AO Research Centre Willingness of cancer survivors to complete patient reported outcomes (PRO) surveys: a pilot study at Flinders Centre for Innovation in Cancer (FCIC), South Australia Prof Marion Eckert Rosemary Bryant

More information

Evaluation of patient reporting to the Yellow Card System. Professor Tony Avery University of Nottingham

Evaluation of patient reporting to the Yellow Card System. Professor Tony Avery University of Nottingham Evaluation of patient reporting to the Yellow Card System Professor Tony Avery University of Nottingham Background Patient reporting to the Yellow Card system began in October 2005 Evaluation funded by

More information

The Metastatic Breast Cancer Patient

The Metastatic Breast Cancer Patient Victoria Harmer RN BSc(Hons) Dip(Br Ca) MBA AKC Team Leader / Clinical Nurse Specialist Breast Care Unit Imperial College Healthcare Trust London The Metastatic Breast Cancer Patient 5 th February 2015

More information

Draft Falls Prevention Strategy

Draft Falls Prevention Strategy Cheshire West & Chester Council Draft Falls Prevention Strategy 2017-2020 Visit: cheshirewestandchester.gov.uk Visit: cheshirewestandchester.gov.uk 02 Cheshire West and Chester Council Draft Falls Prevention

More information

YOUR SOLUTION TO MEDICAL UNCERTAINTY members.bestdoctors.com

YOUR SOLUTION TO MEDICAL UNCERTAINTY members.bestdoctors.com YOUR SOLUTION TO MEDICAL UNCERTAINTY WHAT IS BEST DOCTORS? Best Doctors is an employer-provided service dedicated to making sure our members are confident in their diagnoses, treatments and understanding

More information

Northumbria Healthcare NHS Foundation Trust. Your guide to discharge from the breast clinic. Issued by the Breast Team

Northumbria Healthcare NHS Foundation Trust. Your guide to discharge from the breast clinic. Issued by the Breast Team Northumbria Healthcare NHS Foundation Trust Your guide to discharge from the breast clinic Issued by the Breast Team This leaflet gives you information about your discharge from the Breast Clinic. Why

More information

The usefulness of EuroQol and McGill Quality of Life questionnaires in palliative care in-patients

The usefulness of EuroQol and McGill Quality of Life questionnaires in palliative care in-patients The usefulness of EuroQol and McGill Quality of Life questionnaires in palliative care in-patients Ewa Deskur-Smielecka, Bogusław Stelcer, Aleksandra Kotlinska-Lemieszek, Katarzyna Wieczorowska-Tobis Poznan

More information

Wales Cancer Patient Experience. Survey Aneurin Bevan University Health Board. Published January 2014

Wales Cancer Patient Experience. Survey Aneurin Bevan University Health Board. Published January 2014 Wales Cancer Patient Experience Survey 2013 Aneurin Bevan University Health Published January 2014 The Wales Cancer Patient Experience Survey was undertaken by Quality Health on behalf of the Welsh Government

More information

Minimally Invasive Surgery Minimised. Primary-care physicians guide to single-incision laparoscopic surgery

Minimally Invasive Surgery Minimised. Primary-care physicians guide to single-incision laparoscopic surgery Minimally Invasive Surgery Minimised Primary-care physicians guide to single-incision laparoscopic surgery The single-incision laparoscopic technique: The latest evolution in minimally invasive surgery

More information

The Obstetrics and Gynaecology Health Psychology Service

The Obstetrics and Gynaecology Health Psychology Service Northumbria Healthcare NHS Foundation Trust The Obstetrics and Gynaecology Health Psychology Service Issued by the Obstetrics and Gynaecology Department Psychological therapy Everyone has different strategies

More information

YOUR SOLUTION TO MEDICAL UNCERTAINTY members.bestdoctors.com

YOUR SOLUTION TO MEDICAL UNCERTAINTY members.bestdoctors.com YOUR SOLUTION TO MEDICAL UNCERTAINTY WHAT IS BEST DOCTORS? Best Doctors is an employer-provided service dedicated to making sure our members are confident in their diagnoses, treatments and understanding

More information

Setting The setting was an outpatients department. The economic study was carried out in the UK.

Setting The setting was an outpatients department. The economic study was carried out in the UK. Effectiveness and cost-effectiveness of three types of physiotherapy used to reduce chronic low back pain disability: a pragmatic randomized trial with economic evaluation Critchley D J, Ratcliffe J, Noonan

More information

Choice of EQ 5D 3L for Economic Evaluation of Community Paramedicine Programs Project

Choice of EQ 5D 3L for Economic Evaluation of Community Paramedicine Programs Project As articulated in the project Charter and PICOT Statement, the Economic Value of Community Paramedicine Programs Study (EV-CP) will seek to determine: The economic value of community paramedicine programs

More information

Evaluation of the Beatbullying Peer Mentoring Programme

Evaluation of the Beatbullying Peer Mentoring Programme Evaluation of the Beatbullying Peer Mentoring Programme Dr Robin Banerjee, School of Psychology, University of Sussex Dr Carol Robinson, School of Education, University of Brighton David Smalley, School

More information

Patient-Centered Endpoints in Oncology

Patient-Centered Endpoints in Oncology Patient-Centered Endpoints in Oncology SIXTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP April 29-30, 2015 Silver Spring, MD Disclaimer The views and opinions expressed in the following slides

More information

PATIENT STUDY INFORMATION LEAFLET

PATIENT STUDY INFORMATION LEAFLET PATIENT STUDY INFORMATION LEAFLET BOOKLET 1 You are invited to take part in this research study. Before you decide, it is important for you to understand why the research is being done and what it will

More information

American Joint Replacement Registry Introductory Webinar for the National Association of Orthopaedic Nurses

American Joint Replacement Registry Introductory Webinar for the National Association of Orthopaedic Nurses American Joint Replacement Registry Introductory Webinar for the National Association of Orthopaedic Nurses June 8, 2017 *Pick up your copy of the slides on our website www.ajrr.net under Events & Webinars*

More information

Working with a Primary Care Trust (PCT) Caroline Hulett Health Promotion & Information Manager

Working with a Primary Care Trust (PCT) Caroline Hulett Health Promotion & Information Manager Working with a Primary Care Trust (PCT) Caroline Hulett Health Promotion & Information Manager What we re going to cover Context: breast cancer in the UK and the importance of early diagnosis Background

More information

FACT SHEET Q Fever and the Australian Q Fever Register

FACT SHEET Q Fever and the Australian Q Fever Register FACT SHEET Q Fever and the The Bare Facts Q Fever Protection Q Fever is an infectious disease that can cause severe illness in some people. People usually get Q Fever from farm animals (cattle, sheep and

More information

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC) L 327/34 COUNCIL RECOMMDATION of 2 December 2003 on cancer screening (2003/878/EC) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular

More information

The STAR Trial: Can Quality of Life Benefit Offset Any Survival Detriment? Summary

The STAR Trial: Can Quality of Life Benefit Offset Any Survival Detriment? Summary The STAR Trial: Can Quality of Life Benefit Offset Any Survival Detriment? Dr Fiona Collinson on behalf of Christopher McCabe, Janet Brown, Julia Brown, Helen Howard, Walter Gregory Society of Clinical

More information

Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy

Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy INTRODUCTION There are three basic goals laying down the therapeutic behavior during the treatment process of hepatitis infection:

More information

Digitally including the socially excluded: perspectives from mental health

Digitally including the socially excluded: perspectives from mental health Digitally including the socially excluded: perspectives from mental health Dr Elizabeth A McKay, Associate Professor Eimear Glendon MSc OT, Geraldine Vacher (CNWL) 23 May 2018 E.Mckay@napier.ac.uk Funded

More information